Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Therapeutic benefits of Alequel found in patients with moderate to severe CD

Oct. 4, 2004

Good safety profile of sargramostim in moderate to severe Crohn's disease

Oct. 4, 2004

Update on the efficacy of ABT-874 in active Crohn's disease

Oct. 1, 2004

New data on the efficacy of onercept in active Crohn's disease

Oct. 1, 2004

Phase I cleared to begin for CDA-1 for C. difficile associated diarrhea

Oct. 1, 2004

Visilizumab mechanism, clinical benefit investigated

Sep. 30, 2004

European CHMP gives positive opinion for extension of indication for Pegasys

Sep. 30, 2004

DA-6034 safe but poorly absorbed in healthy subjects

Sep. 29, 2004

Y-40138 protective in hepatitis models

Sep. 29, 2004

Update on the efficacy of cilansetron in diarrhea-predominant IBS

Sep. 29, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...